RT Journal Article
SR Electronic
A1 Cunningham, Muriel
T1 Highlights and Future Directions in AI Clinical Research
JF MD Conference Express
YR 2014
FD SAGE Publications
VO 14
IS 56
SP 16
OP 16
DO 10.1177/1559897715572118
UL http://mdc.sagepub.com/content/14/56/16.abstract
AB Aromatase inhibitors are important agents used for the adjuvant treatment of early hormone receptor-positive breast cancer in postmenopausal women. Studies in early stage breast cancer are ongoing to determine if the cellular proliferation biomarker Ki67 predicts patient response to therapy. Genetic analysis of biopsy specimens may help identify resistance mechanisms.